CARLIER, Jeremy
 Distribuzione geografica
Continente #
NA - Nord America 3.620
AS - Asia 1.710
EU - Europa 1.393
SA - Sud America 312
AF - Africa 127
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.177
Nazione #
US - Stati Uniti d'America 3.539
SG - Singapore 518
IT - Italia 361
VN - Vietnam 329
CN - Cina 286
RU - Federazione Russa 268
HK - Hong Kong 238
BR - Brasile 228
IE - Irlanda 127
SE - Svezia 123
FR - Francia 104
GB - Regno Unito 101
DE - Germania 98
IN - India 82
NL - Olanda 47
CI - Costa d'Avorio 42
MX - Messico 42
FI - Finlandia 37
BD - Bangladesh 35
JP - Giappone 34
CA - Canada 29
IQ - Iraq 25
AR - Argentina 24
TR - Turchia 24
ID - Indonesia 22
PL - Polonia 21
BE - Belgio 20
ZA - Sudafrica 19
PK - Pakistan 17
AT - Austria 16
ES - Italia 16
EC - Ecuador 15
MA - Marocco 15
KR - Corea 14
PH - Filippine 14
TH - Thailandia 12
UA - Ucraina 12
VE - Venezuela 12
KE - Kenya 11
CO - Colombia 10
LT - Lituania 10
AU - Australia 9
CL - Cile 9
EG - Egitto 9
SA - Arabia Saudita 8
IR - Iran 7
JO - Giordania 7
RO - Romania 7
TN - Tunisia 7
DZ - Algeria 6
NG - Nigeria 6
AE - Emirati Arabi Uniti 5
GH - Ghana 5
PE - Perù 5
TW - Taiwan 5
IL - Israele 4
NZ - Nuova Zelanda 4
OM - Oman 4
BY - Bielorussia 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
JM - Giamaica 3
MD - Moldavia 3
PT - Portogallo 3
PY - Paraguay 3
UY - Uruguay 3
UZ - Uzbekistan 3
AL - Albania 2
BO - Bolivia 2
ET - Etiopia 2
HN - Honduras 2
KH - Cambogia 2
ML - Mali 2
MY - Malesia 2
NP - Nepal 2
PS - Palestinian Territory 2
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
PA - Panama 1
RS - Serbia 1
SI - Slovenia 1
Totale 7.173
Città #
Ashburn 886
Dallas 545
Singapore 299
Chandler 282
San Jose 244
Hong Kong 224
Dublin 125
The Dalles 112
Boardman 106
Des Moines 106
Ho Chi Minh City 105
Beijing 89
Los Angeles 81
Hanoi 76
Fairfield 75
Lauterbourg 63
New York 53
Moscow 50
Ancona 44
Abidjan 42
Council Bluffs 40
Lawrence 40
Princeton 40
Chicago 39
Rome 36
Seattle 35
Munich 34
Houston 32
São Paulo 28
London 26
Milan 26
Tokyo 26
Turin 26
Woodbridge 26
Santa Clara 25
Washington 24
Cambridge 23
Jacksonville 22
Warsaw 21
Brussels 19
Denver 19
Frankfurt am Main 19
Helsinki 19
Orem 19
Hefei 18
Buffalo 17
Columbus 17
Da Nang 17
Turku 17
Wilmington 17
Chennai 16
Haiphong 15
Phoenix 14
San Diego 13
Tolentino 13
Mexico City 12
Poplar 12
Amsterdam 11
Baghdad 11
Montreal 11
San Mateo 11
Nairobi 10
Shanghai 10
Shenzhen 10
Vienna 10
Johannesburg 9
Nuremberg 9
Pune 9
Salt Lake City 9
Ann Arbor 8
Atlanta 8
Elk Grove Village 8
Naples 8
Rancho Palos Verdes 8
Stockholm 8
Amman 7
Boydton 7
Brooklyn 7
Guangzhou 7
Manchester 7
Querétaro 7
Quito 7
Ankara 6
Boston 6
City of London 6
Detroit 6
Goiânia 6
Miami 6
San Francisco 6
Seoul 6
Accra 5
Ahmedabad 5
Biên Hòa 5
Bologna 5
Brisbane 5
Buenos Aires 5
Can Tho 5
Caracas 5
Dhaka 5
Erbil 5
Totale 4.784
Nome #
Chlorthalidone In Vitro Metabolite Identification for Documenting Exposure in Doping 286
Human diagnostic markers for intake of semi-synthetic cannabinoids (9R)- and (9S)-hexahydrocannabinol 226
In silico and in vitro human metabolism of IOX2, a performance-enhancing doping agent 178
Drug-facilitated sexual assaults (DFSA): A serious underestimated issue 171
New challenges in clinical and forensic toxicology 168
Acute Intoxications and Fatalities Associated with Benzimidazole Opioid (Nitazene Analog) Use: A Systematic Review 162
3-CMC, 4-CMC, and 4-BMC Human Metabolic Profiling: New Major Pathways to Document Consumption of Methcathinone Analogues? 146
Monitoring Prenatal Exposure to Buprenorphine and Methadone 146
Pharmacology of herbal sexual enhancers: A review of psychiatric and neurological adverse effects 142
A 2017-2019 Update on Acute Intoxications and Fatalities from Illicit Fentanyl and Analogs 138
Pyrrolidinyl synthetic cathinones α-php and 4f-α-pvp metabolite profiling using human hepatocyte incubations 133
In silico prediction, LC-HRMS/MS analysis, and targeted/untargeted data-mining workflow for the profiling of phenylfentanyl in vitro metabolites 131
Disposition of Hexahydrocannabinol Epimers and Their Metabolites in Biological Matrices following a Single Administration of Smoked Hexahydrocannabinol: A Preliminary Study 127
Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids 127
QuEChERS Extraction and Simultaneous Quantification in GC-MS/MS of Hexahydrocannabinol Epimers and Their Metabolites in Whole Blood, Urine, and Oral Fluid 125
β'-Phenylfentanyl Metabolism in Primary Human Hepatocyte Incubations: Identification of Potential Biomarkers of Exposure in Clinical and Forensic Toxicology 125
In vitro, in vivo metabolism and quantification of the novel synthetic opioid N-piperidinyl etonitazene (etonitazepipne) 123
Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances 123
Human metabolism of four synthetic benzimidazole opioids: isotonitazene, metonitazene, etodesnitazene, and metodesnitazene 123
3F-α-pyrrolydinovalerophenone (3F-α-PVP) in vitro human metabolism: Multiple in silico predictions to assist in LC-HRMS/MS analysis and targeted/untargeted data mining 121
Exploring the Metabolism of Flubrotizolam, a Potent Thieno-Triazolo Diazepine, Using Human Hepatocytes and High-Resolution Mass Spectrometry 120
Use of cognitive enhancers: Methylphenidate and analogs 120
Advances in forensic toxicology 120
Ultra-high-performance liquid chromatography-tandem mass spectrometry assay for quantifying fentanyl and 22 analogs and metabolites in whole blood, urine, and hair 119
In Vitro and In Vivo Human Metabolism of Ostarine, a Selective Androgen Receptor Modulator and Doping Agent 115
Cannabidiol adverse effects and toxicity 114
Monitoring Perinatal Exposure to Cannabis and Synthetic Cannabinoids 114
Biomarkers of 4-hydroxy-N,N-methylpropyltryptamine (4-OH-MPT) intake identified from human hepatocyte incubations 112
Dipyanone, a new methadone-like synthetic opioid: In vitro and in vivo human metabolism and pharmacological profiling 111
Distinguishing intake of new synthetic cannabinoids ADB-PINACA and 5F-ADB-PINACA with human hepatocyte metabolites and high-resolution mass spectrometry 111
Development of an enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of methorphan and its O-demethylated metabolite in human blood and its application to post-mortem samples 107
Measurement uncertainty in forensic toxicology 106
Metabolism Study of Anamorelin, a GHSR1a Receptor Agonist Potentially Misused in Sport, with Human Hepatocytes and LC-HRMS/MS 104
Quantification of Carbonic Anhydrase Inhibitors and Metabolites in Urine and Hair of Patients and Their Relatives 102
“Tranq-dope”: The first fatal intoxication due to xylazine-adulterated heroin in Italy 100
In silico, in vitro, and in vivo human metabolism of acetazolamide, a carbonic anhydrase inhibitor and common “diuretic and masking agent” in doping 98
A validated method for quantifying hypoglycin A in whole blood by UHPLC-HRMS/MS 94
UHPLC-MS-MS Determination of THC, CBD and Their Metabolites in Whole Blood of Light Cannabis Smokers 92
Fatal intoxication after taking iboga: GC-MS/MS determination of ibogaine and ibogamine in iboga roots and post-mortem material 92
Fatal intoxication due to ackee (Blighia sapida) in Suriname and French Guyana. GC-MS detection and quantification of hypoglycin-A 88
Update on Cannabidiol Clinical Toxicity and Adverse Effects: a Systematic Review 87
In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201) 86
α-Methyltryptamine (α-MT) Metabolite Profiling in Human Hepatocyte Incubations and Postmortem Urine and Blood 85
The principal toxic glycosidic steroids in Cerbera manghas L. seeds: Identification of cerberin, neriifolin, tanghinin and deacetyltanghinin by UHPLC-HRMS/MS, quantification by UHPLC-PDA-MS 85
25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry 85
A validated method for quantifying atractyloside and carboxyatractyloside in blood by hplc-hrms/ms, a non-fatal case of intoxication with atractylis gummifera l 84
Human Hepatocyte 4-Acetoxy-N,N-Diisopropyltryptamine Metabolite Profiling by Reversed-Phase Liquid Chromatography Coupled with High-Resolution Tandem Mass Spectrometry 83
Pharmacodynamic effects, pharmacokinetics, and metabolism of the synthetic cannabinoid AM-2201 in male rats 83
Protodioscin, a natural saponin with potential steroidogenic effects: metabolic and analytical considerations 82
Atropine eye drops: An unusual homicidal poisoning 82
Metabolism and detection of designer benzodiazepines: a systematic review 80
Identification of alexamorelin consumption biomarkers using human hepatocyte incubations and high-resolution mass spectrometry 80
Synthetic cannabinoid BB-22 (QUCHIC): Human hepatocytes metabolism with liquid chromatography-high resolution mass spectrometry detection 80
Human hepatocyte metabolism of novel synthetic cannabinoids MN-18 and its 5-fluoro analog 5F-MN-18 80
Fatal case of a 27-year-old male after taking iboga in withdrawal treatment: GC-MS/MS determination of ibogaine and ibogamine in iboga roots and postmortem biological material 77
Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes 76
In vitro metabolite profiling of ADB-FUBINACA, a new synthetic cannabinoid 73
Screening approach by ultra-high performance liquid chromatography-tandem mass spectrometry for the blood quantification of thirty-four toxic principles of plant origin. Application to forensic toxicology 72
Quantification of [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone (AM-2201) and 13 metabolites in human and rat plasma by liquid chromatography-tandem mass spectrometry 67
Quantification of pregabalin using hydrophilic interaction hplc-high-resolution ms in postmortem human samples: Eighteen case reports 67
In vivo and in vitro metabolism of the designer benzodiazepine, bretazenil: a comparison of pooled human hepatocytes and liver microsomes with postmortem urine and blood samples 65
In vitro, in vivo and in silico metabolic profiling of α-pyrrolidinopentiothiophenone, a novel thiophene stimulant 62
Metabolism of the new synthetic cannabinoid EG-018 in human hepatocytes by high-resolution mass spectrometry 57
In vitro metabolism of new synthetic cannabinoid SDB-006 in human hepatocytes by high-resolution mass spectrometry 56
Human metabolism and pharmacological profiling of protonitazepyne and metonitazepyne, two highly potent nitazenes: prediction of main metabolite activity based on µ-opioid receptor docking simulations 55
Comparison of authentic urine N-ethylpentedrone metabolites to predicted in silico and in vitro human hepatocyte metabolism 54
Synthetic cannabinoids: Analytical methods 51
Quantification of hypoglycin A in serum using aTRAQ® assay 49
Insights into the human metabolism and in silico receptor activity of gidazepam and desalkylgidazepam 45
Structure-activity relationship of prevalent synthetic cannabinoid metabolites on hCB1 in vitro and in silico dynamics 39
In Vitro Metabolism of a Benzofuran-Substituted Nitazene: Ethyleneoxynitazene 36
Synthetic cannabinoid receptor agonists containing silicon: exploring the metabolic pathways of ADMB- and Cumyl-3TMS-PrINACA in human urine specimens and post mortem material compared to in vitro and in silico data 34
Totale 7.357
Categoria #
all - tutte 31.450
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.450


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202167 0 0 0 0 0 0 0 0 0 11 27 29
2021/2022235 0 16 2 2 1 15 4 7 14 18 94 62
2022/2023824 57 95 49 77 51 182 2 54 178 7 46 26
2023/2024543 65 19 78 75 91 83 17 15 4 21 24 51
2024/20251.376 101 93 26 49 78 73 164 64 206 149 197 176
2025/20264.180 269 584 287 397 449 226 831 398 379 360 0 0
Totale 7.357